Legend Biotech Corp ADR (LEGN) saw an uptrend of 3167811% in the recent trading with $1770000.0 being its most recent. The current price level -45.08% lower than the highest price of $60.87 marked by the stock while trading over the past 52-weeks, whereas it is 22.28% higher than the lowest price of $27.34 the company dropped to over past 52-weeks. The latest news story on LEGN appeared in (Investor’s Business Daily) under the title “The FDA Shake-Up Continues, And Could Impact Genetic Medicines” on Jun-20-25.
Do analysts rate it as a buy, sell or hold?
Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Currently, the stock has been recommended as Strong Buy by 11 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.19 for the stock.
Legend Biotech Corp ADR Earnings – What Happened With LEGN
Coming around sales and income figures on LEGN Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.
Legend Biotech Corp ADR – Insider Activity and Holdings
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 184.03 million. LEGN does have institutional investors; and they hold 46.74% of the stock.
As on 2024-06-30, FMR LLC was the top most holder in Legend Biotech Corp ADR (NASDAQ:LEGN) with an ownership of 17.62 million shares of the company or 9.6503 of the stake worth $780.46 million. The filing also reveals PRICE T ROWE ASSOCIATES INC /MD/ as the second largest holder in the company with a control over 6.292 of the outstanding shares. Its stake is worth $508.86 million for having 11.49 million shares in hand.
RA CAPITAL MANAGEMENT, L.P. also came holding a key position in the company during the recent quarter and it now holds 4.1111 of the outstanding shares. With this there are now 338.0 institutions which have possession in LEGN’s shares.
Key Metrics forLEGN
The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, Legend Biotech Corp ADR has a debt to equity ratio of 0.36.
Technical Analysis of Legend Biotech Corp ADR (NASDAQ:LEGN) stock
To comprehend better with the trade moves and investors’ behavior, exploring the short, medium and long term technical indicators along with average volume of a stock is an effective way to make use of. When looking into those indicators for Legend Biotech Corp ADR (LEGN), we notice that the stock’s 20-day average volume is at 2,155,740 shares. Medium term indicators at an average of 50% are spotting the stock at Sell with its 50-day average volume of 1,896,808 shares. And to end, LEGN’s 100-day average volume is 1,562,611 shares with 100% of the long-term indicators pointing towards Sell for the stock.
